Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 9 |
| Dec 2025 | 0 | 13 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 19, 2024 Filed Mar 20, 2024 21:36 UTC |
Gagnon Robert E.Director
|
SaleCommon Stock | 130 | $10.38 | $1,349.40 |
DisclosureSEC source: 0001104659-24-036792 · tm249354-3_4seq1.xml · nonDerivative · entry 2 Gagnon Robert E. · CIK 0001504983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,391 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 21:34 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 182 | $10.38 | $1,889.16 |
DisclosureSEC source: 0001104659-24-036790 · tm249354-2_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,490 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 21:32 UTC |
Stuglik Brian MDirector
|
SaleCommon Stock | 537 | $10.71 | $5,751.27 |
DisclosureSEC source: 0001104659-24-036787 · tm249354-1_4seq1.xml · nonDerivative · entry 1 Stuglik Brian M · CIK 0001716328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,913 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 21:36 UTC |
Gagnon Robert E.Director
|
SaleCommon Stock | 283 | $10.71 | $3,030.93 |
DisclosureSEC source: 0001104659-24-036792 · tm249354-3_4seq1.xml · nonDerivative · entry 1 Gagnon Robert E. · CIK 0001504983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,521 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 21:34 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 244 | $10.71 | $2,613.24 |
DisclosureSEC source: 0001104659-24-036790 · tm249354-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,672 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:10 UTC |
ROBERTSON MICHELLEDirector
|
GrantStock Option (right to buy) · Derivative | 5,291 | Not disclosed Strike: $11.44 | Not disclosed |
DisclosureSEC source: 0001104659-24-034035 · tm248737-2_4seq1.xml · derivative · entry 2 ROBERTSON MICHELLE · CIK 0001755098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,291 Underlying: Common Stock · 5,291 shares Expires 2034-03-11 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 5,291 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F1 · derivative.exercise_date: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 5,291 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:10 UTC |
ROBERTSON MICHELLEDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 5,291 | Not disclosed Strike: $37.32 | Not disclosed |
DisclosureSEC source: 0001104659-24-034035 · tm248737-2_4seq1.xml · derivative · entry 1 ROBERTSON MICHELLE · CIK 0001755098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,291 shares Expires 2031-11-15 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 5,291 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F2 · derivative.exercise_date: The canceled stock option was granted on November 15, 2021 and provided for vesting in twelve equal month installments beginning on the on the last day of each month over a period from November 2021 to October 2022. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:17 UTC |
Stuglik Brian MDirector
|
GrantStock Option (right to buy) · Derivative | 11,865 | Not disclosed Strike: $11.44 | Not disclosed |
DisclosureSEC source: 0001104659-24-034044 · tm248737-7_4seq1.xml · derivative · entry 3 Stuglik Brian M · CIK 0001716328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,865 Underlying: Common Stock · 11,865 shares Expires 2034-03-11 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F1 · derivative.exercise_date: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:17 UTC |
Stuglik Brian MDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 7,699 | Not disclosed Strike: $21.72 | Not disclosed |
DisclosureSEC source: 0001104659-24-034044 · tm248737-7_4seq1.xml · derivative · entry 2 Stuglik Brian M · CIK 0001716328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,083 shares Expires 2029-06-21 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F3 · derivative.exercise_date: The canceled stock option was granted on June 21, 2019 and provided for vesting in twelve equal monthly installments beginning on July 21, 2019 and ending on June 21, 2020. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:17 UTC |
Stuglik Brian MDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 4,166 | Not disclosed Strike: $59.04 | Not disclosed |
DisclosureSEC source: 0001104659-24-034044 · tm248737-7_4seq1.xml · derivative · entry 1 Stuglik Brian M · CIK 0001716328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,157 shares Expires 2028-06-11 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F2 · derivative.exercise_date: The canceled stock option was granted on June 21, 2018 and provided for vesting in twelve equal monthly installments beginning on October 2, 2017 ending on September 2, 2018. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:14 UTC |
JOHNSON JOHNDirector
|
GrantStock Option (right to buy) · Derivative | 8,549 | Not disclosed Strike: $11.44 | Not disclosed |
DisclosureSEC source: 0001104659-24-034041 · tm248737-5_4seq1.xml · derivative · entry 5 JOHNSON JOHN · CIK 0001410781 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,549 Underlying: Common Stock · 8,549 shares Expires 2034-03-11 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange,the Reporting Person received a grant of 8,549 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F1 · derivative.exercise_date: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange,the Reporting Person received a grant of 8,549 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:14 UTC |
JOHNSON JOHNDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,083 | Not disclosed Strike: $49.92 | Not disclosed |
DisclosureSEC source: 0001104659-24-034041 · tm248737-5_4seq1.xml · derivative · entry 4 JOHNSON JOHN · CIK 0001410781 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,083 shares Expires 2031-06-28 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange,the Reporting Person received a grant of 8,549 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F5 · derivative.exercise_date: The canceled stock option was granted on June 28, 2021 and provided for vesting in twelve equal month installments beginning on the on the last day of each month over a period from June 2021 to May 2022. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:14 UTC |
JOHNSON JOHNDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,300 | Not disclosed Strike: $21.24 | Not disclosed |
DisclosureSEC source: 0001104659-24-034041 · tm248737-5_4seq1.xml · derivative · entry 3 JOHNSON JOHN · CIK 0001410781 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,300 shares Expires 2030-06-16 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange,the Reporting Person received a grant of 8,549 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F4 · derivative.exercise_date: The canceled stock option was granted on June 16, 2020 and provided for vesting in twelve equal monthly installments beginning on June 30, 2020 and ending on May 31, 2021. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:14 UTC |
JOHNSON JOHNDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,083 | Not disclosed Strike: $21.72 | Not disclosed |
DisclosureSEC source: 0001104659-24-034041 · tm248737-5_4seq1.xml · derivative · entry 2 JOHNSON JOHN · CIK 0001410781 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,083 shares Expires 2030-04-29 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange,the Reporting Person received a grant of 8,549 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F3 · derivative.exercise_date: The canceled stock option was granted on April 29, 2020 and provided for vesting in twelve equal monthly beginning on May 29, 2020 and ending on April 29, 2021. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:14 UTC |
JOHNSON JOHNDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,083 | Not disclosed Strike: $15.60 | Not disclosed |
DisclosureSEC source: 0001104659-24-034041 · tm248737-5_4seq1.xml · derivative · entry 1 JOHNSON JOHN · CIK 0001410781 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,083 shares Expires 2030-01-03 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange,the Reporting Person received a grant of 8,549 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F2 · derivative.exercise_date: The canceled stock option was granted on January 3, 2020 and provided for cliff vesting on June 3, 2021. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:16 UTC |
Rowinsky Eric KDirector
|
GrantStock Option (right to buy) · Derivative | 12,572 | Not disclosed Strike: $11.44 | Not disclosed |
DisclosureSEC source: 0001104659-24-034043 · tm248737-6_4seq1.xml · derivative · entry 6 Rowinsky Eric K · CIK 0001318886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,572 Underlying: Common Stock · 12,572 shares Expires 2034-03-11 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F1 · derivative.exercise_date: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:16 UTC |
Rowinsky Eric KDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,083 | Not disclosed Strike: $49.92 | Not disclosed |
DisclosureSEC source: 0001104659-24-034043 · tm248737-6_4seq1.xml · derivative · entry 5 Rowinsky Eric K · CIK 0001318886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,083 shares Expires 2031-06-28 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F6 · derivative.exercise_date: The canceled stock option was granted on June 28, 2021 and provided for vesting in twelve equal month installments beginning on the on the last day of each month over a period from June 2021 to May 2022. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:16 UTC |
Rowinsky Eric KDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,083 | Not disclosed Strike: $21.24 | Not disclosed |
DisclosureSEC source: 0001104659-24-034043 · tm248737-6_4seq1.xml · derivative · entry 4 Rowinsky Eric K · CIK 0001318886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,083 shares Expires 2030-06-16 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F5 · derivative.exercise_date: The canceled stock option was granted on June 16, 2020 and provided for vesting in twelve equal monthly installments beginning on June 30, 2020 and ending on May 31, 2021. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:16 UTC |
Rowinsky Eric KDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,083 | Not disclosed Strike: $21.72 | Not disclosed |
DisclosureSEC source: 0001104659-24-034043 · tm248737-6_4seq1.xml · derivative · entry 3 Rowinsky Eric K · CIK 0001318886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,083 shares Expires 2029-06-21 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F4 · derivative.exercise_date: The canceled stock option was granted on June 21, 2019 and provided for vesting in twelve equal monthly installments beginning on July 21, 2019 and ending on June 21, 2020. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:16 UTC |
Rowinsky Eric KDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,157 | Not disclosed Strike: $67.08 | Not disclosed |
DisclosureSEC source: 0001104659-24-034043 · tm248737-6_4seq1.xml · derivative · entry 2 Rowinsky Eric K · CIK 0001318886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,157 shares Expires 2028-06-11 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F3 · derivative.exercise_date: The canceled stock option was granted on June 21, 2018 and provided for vesting in twelve equal monthly installments beginning on July 11, 2018 ending on June 11, 2019. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:16 UTC |
Rowinsky Eric KDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 4,166 | Not disclosed Strike: $25.08 | Not disclosed |
DisclosureSEC source: 0001104659-24-034043 · tm248737-6_4seq1.xml · derivative · entry 1 Rowinsky Eric K · CIK 0001318886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,166 shares Expires 2027-06-13 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F2 · derivative.exercise_date: The canceled stock option was granted on June 13, 2017 and provided for vesting in twelve monthly installments through June 13, 2018, with the first monthly installment vesting on July 13, 2017. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:07 UTC |
Kauffman MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 16,078 | Not disclosed Strike: $11.44 | Not disclosed |
DisclosureSEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 9 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,078 Underlying: Common Stock · 16,078 shares Expires 2034-03-11 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F1 · derivative.exercise_date: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:07 UTC |
Kauffman MichaelDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,083 | Not disclosed Strike: $49.92 | Not disclosed |
DisclosureSEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 8 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,083 shares Expires 2031-06-28 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F9 · derivative.exercise_date: The canceled stock option was granted on June 28, 2021 and provided for vesting in twelve equal month installments beginning on the on the last day of each month over a period from June 2021 to May 2022. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:07 UTC |
Kauffman MichaelDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,083 | Not disclosed Strike: $21.24 | Not disclosed |
DisclosureSEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 7 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,083 shares Expires 2030-06-16 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F8 · derivative.exercise_date: The canceled stock option was granted on June 16, 2020 and provided for vesting in twelve equal monthly installments beginning on June 30, 2020 and ending on May 31, 2021. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:07 UTC |
Kauffman MichaelDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,083 | Not disclosed Strike: $21.72 | Not disclosed |
DisclosureSEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 6 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,083 shares Expires 2029-06-21 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F7 · derivative.exercise_date: The canceled stock option was granted on June 21, 2019 and provided for vesting in twelve equal monthly installments beginning on July 21, 2019 and ending on June 21, 2020. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:07 UTC |
Kauffman MichaelDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,083 | Not disclosed Strike: $67.08 | Not disclosed |
DisclosureSEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 5 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,083 shares Expires 2028-06-11 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F6 · derivative.exercise_date: The canceled stock option was granted on June 21, 2018 and provided for vesting in twelve equal monthly installments beginning on July 11, 2018 ending on June 11, 2019. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:07 UTC |
Kauffman MichaelDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,083 | Not disclosed Strike: $25.08 | Not disclosed |
DisclosureSEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 4 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,083 shares Expires 2027-06-13 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F5 · derivative.exercise_date: The canceled stock option was granted on June 13, 2017 and provided for vesting in twelve monthly installments through June 13, 2018, with the first monthly installment vesting on July 13, 2017. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:07 UTC |
Kauffman MichaelDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,083 | Not disclosed Strike: $16.44 | Not disclosed |
DisclosureSEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 3 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,083 shares Expires 2026-06-13 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F4 · derivative.exercise_date: The canceled stock option was granted on June 14, 2016 and provided for vesting in twelve monthly installments through June 14, 2017, with the first monthly installment vesting on July 14, 2016. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:07 UTC |
Kauffman MichaelDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,497 | Not disclosed Strike: $95.88 | Not disclosed |
DisclosureSEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 2 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,497 shares Expires 2025-06-11 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F3 · derivative.exercise_date: The canceled stock option was granted on June 12, 2015 and provided for vesting in twelve monthly installments through June 12, 2016, with the first monthly installment vesting on July 12, 2015. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:07 UTC |
Kauffman MichaelDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,083 | Not disclosed Strike: $120.84 | Not disclosed |
DisclosureSEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 1 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,083 shares Expires 2024-06-10 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F2 · derivative.exercise_date: The canceled stock option was granted on June 10, 2014 and provided for vesting in twelve equal monthly installments from June 10, 2014 until June 10, 2015. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:18 UTC |
Bunn Paul A.Director
|
GrantStock Option (right to buy) · Derivative | 6,113 | Not disclosed Strike: $11.44 | Not disclosed |
DisclosureSEC source: 0001104659-24-034045 · tm248737-8_4seq1.xml · derivative · entry 2 Bunn Paul A. · CIK 0001868760 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,113 Underlying: Common Stock · 6,113 shares Expires 2034-03-11 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 6,113 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F1 · derivative.exercise_date: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 6,113 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:18 UTC |
Bunn Paul A.Director
|
Disposition to issuerStock Option (right to buy) · Derivative | 6,113 | Not disclosed Strike: $53.16 | Not disclosed |
DisclosureSEC source: 0001104659-24-034045 · tm248737-8_4seq1.xml · derivative · entry 1 Bunn Paul A. · CIK 0001868760 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,113 shares Expires 2031-06-24 F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 6,113 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date. F2 · derivative.exercise_date: The canceled stock option was granted on June 24, 2021, and provided for vesting in twelve equal month installments beginning on the last day of each month over a period from June 2021 to May 2022. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC |
Paterson DanDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 23,843 | Not disclosed Strike: $11.44 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 14 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,843 Underlying: Common Stock · 23,843 shares Expires 2034-03-11 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F1 · derivative.exercise_date: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC |
Paterson DanDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 144,137 | Not disclosed Strike: $11.44 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 13 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,137 Underlying: Common Stock · 144,137 shares Expires 2034-03-11 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F1 · derivative.exercise_date: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC |
Paterson DanDirector · President and CEO
|
Disposition to issuerStock Option (right to buy) · Derivative | 30,708 | Not disclosed Strike: $28.32 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 12 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,708 shares Expires 2031-01-04 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F13 · derivative.exercise_date: The canceled option was granted on December 15, 2021 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period following the first anniversary of the grant date until the fourth anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC |
Paterson DanDirector · President and CEO
|
Disposition to issuerStock Option (right to buy) · Derivative | 33,962 | Not disclosed Strike: $26.40 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 11 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,962 shares Expires 2030-12-18 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F12 · derivative.exercise_date: The canceled option was granted on December 18, 2020 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period following the first anniversary of the grant date until the fourth anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC |
Paterson DanDirector · President and CEO
|
Disposition to issuerStock Option (right to buy) · Derivative | 12,500 | Not disclosed Strike: $16.08 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 10 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2029-12-13 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F11 · derivative.exercise_date: The canceled option was granted on December 13, 2019 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until the fourth anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC |
Paterson DanDirector · President and CEO
|
Disposition to issuerStock Option (right to buy) · Derivative | 16,666 | Not disclosed Strike: $16.08 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 9 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,666 shares Expires 2029-12-13 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F10 · derivative.exercise_date: The canceled option was granted on December 13, 2019 and provided for vesting as to 50% of the shares underlying the option on the first anniversary of the grant date and vesting as to 12.5% of the shares underlying the option at the end of each successive three-month period following the first anniversary of grant date until the second anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC |
Paterson DanDirector · President and CEO
|
Disposition to issuerStock Option (right to buy) · Derivative | 20,832 | Not disclosed Strike: $21.72 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 8 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,832 shares Expires 2029-06-21 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F9 · derivative.exercise_date: The canceled option was granted on June 21, 2019 and provided for vesting as to 50% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 12.5% of the shares underlying the option on each successive three month period after such date until the second anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC |
Paterson DanDirector · President and CEO
|
Disposition to issuerStock Option (right to buy) · Derivative | 6,250 | Not disclosed Strike: $42.12 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 7 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,250 shares Expires 2029-01-03 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F8 · derivative.exercise_date: The canceled option was granted on January 3, 2019 and provided for vesting as to 25% of the shares underlying the option on January 1, 2020 and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until January 1, 2023. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC |
Paterson DanDirector · President and CEO
|
Disposition to issuerStock Option (right to buy) · Derivative | 3,750 | Not disclosed Strike: $35.64 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 6 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires 2028-01-05 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F7 · derivative.exercise_date: The canceled option was granted on January 5, 2018 and provided for vesting based on the achievement of certain performance milestones which were met by June 30, 2018 and by March 31, 2019. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC |
Paterson DanDirector · President and CEO
|
Disposition to issuerStock Option (right to buy) · Derivative | 6,249 | Not disclosed Strike: $35.64 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 5 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,249 shares Expires 2028-01-05 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F6 · derivative.exercise_date: The canceled option was granted on January 5, 2018 and provided for vesting as to 25% of the shares underlying the option on January 1, 2019 and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until January 1, 2022. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC |
Paterson DanDirector · President and CEO
|
Disposition to issuerStock Option (right to buy) · Derivative | 8,333 | Not disclosed Strike: $16.44 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 4 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,333 shares Expires 2026-06-13 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F5 · derivative.exercise_date: The canceled option was granted on June 14, 2016 and provided for vesting as to 50% of the shares underlying the option upon satisfaction of a certain performance milestone met in June 2017, and vesting as to the remaining 50% of the shares underlying the option upon satisfaction of a certain performance milestone met in September 2017. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC |
Paterson DanDirector · President and CEO
|
Disposition to issuerStock Option (right to buy) · Derivative | 5,500 | Not disclosed Strike: $22.32 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 3 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,500 shares Expires 2025-12-31 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F4 · derivative.exercise_date: The canceled option was granted on January 1, 2016 and provided for vesting as to 50% of the shares underlying the option on November 9, 2016, and vesting as to the remaining 50% of the shares underlying the option on November 9, 2017. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC |
Paterson DanDirector · President and CEO
|
Disposition to issuerStock Option (right to buy) · Derivative | 11,166 | Not disclosed Strike: $25.56 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,166 shares Expires 2025-11-08 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F3 · derivative.exercise_date: The canceled option was granted on November 9, 2015 and provided for vesting as to 50% of the shares underlying the option on the first anniversary of the grant date, and vesting as to the remaining 50% of the shares underlying the option on the second anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC |
Paterson DanDirector · President and CEO
|
Disposition to issuerStock Option (right to buy) · Derivative | 12,064 | Not disclosed Strike: $110.28 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,064 shares Expires 2025-01-08 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F2 · derivative.exercise_date: The canceled option was granted on January 8, 2015 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period following the first anniversary of the grant date until the fourth anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:11 UTC |
Calkins DanielChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 1,175 | Not disclosed Strike: $11.44 | Not disclosed |
DisclosureSEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 8 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,175 Underlying: Common Stock · 1,175 shares Expires 2034-03-11 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F1 · derivative.exercise_date: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:11 UTC |
Calkins DanielChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 5,413 | Not disclosed Strike: $11.44 | Not disclosed |
DisclosureSEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 7 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,413 Underlying: Common Stock · 5,413 shares Expires 2034-03-11 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F1 · derivative.exercise_date: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:11 UTC |
Calkins DanielChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,875 | Not disclosed Strike: $27.72 | Not disclosed |
DisclosureSEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 6 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,875 shares Expires 2031-12-23 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F7 · derivative.exercise_date: The canceled option was granted on December 23, 2021 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until the fourth anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:11 UTC |
Calkins DanielChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 750 | Not disclosed Strike: $26.40 | Not disclosed |
DisclosureSEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 5 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 750 shares Expires 2031-01-04 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F6 · derivative.exercise_date: The canceled option was granted on January 4, 2021 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until the fourth anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.